Hagerty David T 4
4 · Ardea Biosciences, Inc./DE · Filed Jun 20, 2012
Insider Transaction Report
Form 4
Hagerty David T
Senior VP & CMO
Transactions
- Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$6.00/sh−134,616$807,696→ 0 totalExercise: $26.00Exp: 2021-02-28→ Common Stock (134,616 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$13.06/sh−33,600$438,816→ 0 totalExercise: $18.94Exp: 2021-12-15→ Common Stock (33,600 underlying) - Disposition to Issuer
Common Stock
2012-06-19$32.00/sh−140$4,480→ 0 total - Disposition to Issuer
Incentive Stock Option (right to buy)
2012-06-19$6.00/sh−15,384$92,304→ 0 totalExercise: $26.00Exp: 2021-02-28→ Common Stock (15,384 underlying)
Footnotes (2)
- [F1]Includes 140 shares acquired under the Ardea Biosciences, Inc. ("Ardea") 2000 Employee Stock Purchase Plan on June 12, 2012.
- [F2]This option was canceled pursuant to the Agreement and Plan of Merger, dated as of April 21, 2012, by and among Ardea, Zeneca Inc. and QAM Corp. (the "Merger Agreement"), in exchange for a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) the excess of $32.00 (the per share merger consideration pursuant to the Merger Agreement) over the exercise price of the option; and (ii) the number of shares of Ardea common stock underlying the option.